ursodeoxycholic acid has been researched along with Glioblastoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brossard, D; Clément, M; El Kihel, L; Khalid, M; Rault, S; Roussakis, C; Sebbahi, W | 1 |
| Chen, A; Huang, B; Li, X; Wang, J; Wang, S; Yao, Z; Zhang, X; Zhao, F | 1 |
| Adeyi, O; Fung, S; Mason, M; Millar, BA | 1 |
3 other study(ies) available for ursodeoxycholic acid and Glioblastoma
| Article | Year |
|---|---|
Synthesis of bile acid derivatives and in vitro cytotoxic activity with pro-apoptotic process on multiple myeloma (KMS-11), glioblastoma multiforme (GBM), and colonic carcinoma (HCT-116) human cell lines.
Topics: Apoptosis; Bile Acids and Salts; Cell Line, Tumor; Colonic Neoplasms; Glioblastoma; Humans; Multiple Myeloma; Piperazine; Piperazines | 2010 |
Ursodeoxycholic Acid Inhibits Glioblastoma Progression via Endoplasmic Reticulum Stress Related Apoptosis and Synergizes with the Proteasome Inhibitor Bortezomib.
Topics: Apoptosis; Bortezomib; Cell Line, Tumor; Endoplasmic Reticulum Stress; Endoribonucleases; Glioblastoma; Humans; Proteasome Inhibitors; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Ursodeoxycholic Acid | 2020 |
Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma.
Topics: Antineoplastic Agents, Alkylating; Biopsy, Needle; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestyramine Resin; Common Bile Duct Diseases; Dacarbazine; Female; Follow-Up Studies; Glioblastoma; Humans; Immunohistochemistry; Jaundice; Liver Function Tests; Middle Aged; Syndrome; Temozolomide; Treatment Outcome; Ursodeoxycholic Acid | 2014 |